Precigen Stock (NASDAQ: PGEN) stock price, news, charts, stock research, profile.
You can purchase shares of Precigen (NASDAQ:PGEN) through any online brokerage.
Other companies in Precigen’s space includes: Molecular Partners (NASDAQ:MOLN), Macrogenics (NASDAQ:MGNX), Zentalis Pharma (NASDAQ:ZNTL), Inozyme Pharma (NASDAQ:INZY) and Larimar Therapeutics (NASDAQ:LRMR).
Precigen has a consensus price target of $7.00.
The stock price for Precigen (NASDAQ: PGEN) is $0.7514 last updated December 24, 2024 at 2:09 PM EST.
There are no upcoming dividends for Precigen.
Precigen’s Q4 earnings are confirmed for Tuesday, March 18, 2025.
There is no upcoming split for Precigen.
Precigen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.